[
  {
    "ticker": "LLY",
    "name": "Lilly (Eli)",
    "marketCap": 940920995840,
    "revenueGrowth": 0.539,
    "debtToEquity": 178.516,
    "trailingPE": 51.55206,
    "momentum_2m": 0.4281230006530785,
    "momentum_1w": 0.03277861904260293,
    "FundamentalFilterRating": 66,
    "price": 1049.5999755859375,
    "RSI (14)": 93.06,
    "EMA (20)": 947.25,
    "MACD (12,26,9)": 57.6125,
    "MACD_Signal (12,26,9)": 46.0379,
    "percent_change": 1.9,
    "TechFilterRating": 75.0,
    "news_sentiment_percent": 66.7,
    "social_sentiment_percent": null,
    "sector": "Healthcare",
    "sector_name": "XLV",
    "market_change_1d": 0.37538357962292324,
    "market_change_5d": -3.0471785979927946,
    "market_change_20d": -0.8544010945476632,
    "market_trend": "down",
    "sector_change_1d": -0.17038764865044964,
    "sector_change_5d": -0.3206422390259922,
    "sector_change_20d": 4.364205826377443,
    "sector_trend": "neutral",
    "OverallRating": 69.2,
    "AITicker": "LLY, známa ako Eli Lilly, je farmaceutická spoločnosť zameraná na vývoj a predaj liekov v sektore zdravotnej starostlivosti.",
    "AIComment": "Akcia LLY ukazuje silný krátkodobý rastový potenciál, napriek negatívnemu trendu na trhu a neutrálnemu trendu v sektore zdravotnej starostlivosti. Vysoký RSI naznačuje, že akcia môže byť prekúpená, čo by mohlo viesť k krátkodobej korekcii. Avšak, silný rast príjmov a pozitívne sentimenty správ podporujú možnosť udržania momentum.",
    "AIScore": 75,
    "SL": 1018.11,
    "TP": 1102.08,
    "SL10": 9.7,
    "TP10": 10.5
  },
  {
    "ticker": "HCA",
    "name": "HCA Healthcare",
    "marketCap": 112564912128,
    "revenueGrowth": 0.096,
    "debtToEquity": null,
    "trailingPE": 18.588099,
    "momentum_2m": 0.198926946671796,
    "momentum_1w": 0.015730268443350237,
    "FundamentalFilterRating": 83,
    "price": 481.05999755859375,
    "RSI (14)": 60.38,
    "EMA (20)": 466.11,
    "MACD (12,26,9)": 9.1772,
    "MACD_Signal (12,26,9)": 8.7761,
    "percent_change": 0.61,
    "TechFilterRating": 100.0,
    "news_sentiment_percent": 66.7,
    "social_sentiment_percent": null,
    "sector": "Healthcare",
    "sector_name": "XLV",
    "market_change_1d": 0.37538357962292324,
    "market_change_5d": -3.0471785979927946,
    "market_change_20d": -0.8544010945476632,
    "market_trend": "down",
    "sector_change_1d": -0.17038764865044964,
    "sector_change_5d": -0.3206422390259922,
    "sector_change_20d": 4.364205826377443,
    "sector_trend": "neutral",
    "OverallRating": 83.2,
    "AITicker": "HCA Healthcare is a healthcare provider, operating hospitals and healthcare facilities primarily in the United States.",
    "AIComment": "Despite a recent downturn in the broader market, HCA Healthcare shows resilience with a positive momentum and a strong news sentiment. The stock's performance is bolstered by a robust RSI and favorable MACD values, suggesting potential for short-term gains. However, the neutral sector trend and recent market volatility could temper the upside.",
    "AIScore": 72,
    "SL": 466.63,
    "TP": 505.11,
    "SL10": 9.7,
    "TP10": 10.5
  },
  {
    "ticker": "FANG",
    "name": "Diamondback Energy",
    "marketCap": 43043692544,
    "revenueGrowth": 0.42,
    "debtToEquity": 35.66,
    "trailingPE": 10.441714,
    "momentum_2m": 0.039971107846324294,
    "momentum_1w": 0.02424746377942677,
    "FundamentalFilterRating": 83,
    "price": 148.69000244140625,
    "RSI (14)": 61.67,
    "EMA (20)": 144.28,
    "MACD (12,26,9)": 1.9289,
    "MACD_Signal (12,26,9)": 1.1726,
    "percent_change": -0.59,
    "TechFilterRating": 100.0,
    "news_sentiment_percent": 66.7,
    "social_sentiment_percent": null,
    "sector": "Energy",
    "sector_name": "XLE",
    "market_change_1d": 0.37538357962292324,
    "market_change_5d": -3.0471785979927946,
    "market_change_20d": -0.8544010945476632,
    "market_trend": "down",
    "sector_change_1d": -1.2958492607212047,
    "sector_change_5d": -0.4099753424731678,
    "sector_change_20d": 2.3690138147649087,
    "sector_trend": "neutral",
    "OverallRating": 83.2,
    "AITicker": "Diamondback Energy, Inc. (FANG) is an energy company primarily engaged in hydrocarbon exploration.",
    "AIComment": "Despite a recent downturn in the broader market, Diamondback Energy shows resilience with a positive momentum and a strong news sentiment. The stock's technical indicators such as a higher RSI and positive MACD above its signal suggest bullish trends. However, the neutral sector trend and recent market volatility could limit upside potential in the short term.",
    "AIScore": 68,
    "SL": 144.23,
    "TP": 154.64,
    "SL10": 9.7,
    "TP10": 10.4
  },
  {
    "ticker": "DHR",
    "name": "Danaher Corporation",
    "marketCap": 159257034752,
    "revenueGrowth": 0.044,
    "debtToEquity": 35.544,
    "trailingPE": 45.669407,
    "momentum_2m": 0.08025649516296052,
    "momentum_1w": 0.013719279167551557,
    "FundamentalFilterRating": 66,
    "price": 222.41000366210938,
    "RSI (14)": 64.16,
    "EMA (20)": 217.18,
    "MACD (12,26,9)": 2.6676,
    "MACD_Signal (12,26,9)": 1.8479,
    "percent_change": -1.37,
    "TechFilterRating": 100.0,
    "news_sentiment_percent": 100.0,
    "social_sentiment_percent": null,
    "sector": "Healthcare",
    "sector_name": "XLV",
    "market_change_1d": 0.37538357962292324,
    "market_change_5d": -3.0471785979927946,
    "market_change_20d": -0.8544010945476632,
    "market_trend": "down",
    "sector_change_1d": -0.17038764865044964,
    "sector_change_5d": -0.3206422390259922,
    "sector_change_20d": 4.364205826377443,
    "sector_trend": "neutral",
    "OverallRating": 88.7,
    "AITicker": "Danaher Corporation is a global science and technology innovator focused on designing, manufacturing, and marketing professional, medical, industrial, and commercial products and services.",
    "AIComment": "Despite a recent downturn in the broader market, Danaher Corporation shows resilience with a positive momentum over the last two months and a stable week. The stock's technical indicators such as a higher RSI and positive MACD values suggest potential for short-term gains. However, the neutral sector trend and recent market downturn could limit upside potential.",
    "AIScore": 65,
    "SL": 215.74,
    "TP": 231.31,
    "SL10": 9.7,
    "TP10": 10.4
  },
  {
    "ticker": "MCK",
    "name": "McKesson Corporation",
    "marketCap": 106033963008,
    "revenueGrowth": 0.101,
    "debtToEquity": null,
    "trailingPE": 26.664686,
    "momentum_2m": 0.2541720899848019,
    "momentum_1w": 0.01393989973609866,
    "FundamentalFilterRating": 83,
    "price": 852.469970703125,
    "RSI (14)": 60.31,
    "EMA (20)": 836.22,
    "MACD (12,26,9)": 15.2346,
    "MACD_Signal (12,26,9)": 14.7179,
    "percent_change": -0.96,
    "TechFilterRating": 100.0,
    "news_sentiment_percent": 66.7,
    "social_sentiment_percent": null,
    "sector": "Healthcare",
    "sector_name": "XLV",
    "market_change_1d": 0.37538357962292324,
    "market_change_5d": -3.0471785979927946,
    "market_change_20d": -0.8544010945476632,
    "market_trend": "down",
    "sector_change_1d": -0.17038764865044964,
    "sector_change_5d": -0.3206422390259922,
    "sector_change_20d": 4.364205826377443,
    "sector_trend": "neutral",
    "OverallRating": 83.2,
    "AITicker": "McKesson Corporation is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology.",
    "AIComment": "Despite a recent downturn in the broader market, McKesson Corporation shows resilience with a positive momentum over the last two months and a stable week-over-week performance. The stock's technical indicators such as a higher RSI and positive MACD values suggest strength, but the negative market trend could limit upside potential in the short term. The neutral sector trend and positive news sentiment provide some support.",
    "AIScore": 65,
    "SL": 826.9,
    "TP": 895.09,
    "SL10": 9.7,
    "TP10": 10.5
  },
  {
    "ticker": "BKR",
    "name": "Baker Hughes",
    "marketCap": 47838797824,
    "revenueGrowth": 0.015,
    "debtToEquity": 33.042,
    "trailingPE": 16.717241,
    "momentum_2m": 0.09584544616882584,
    "momentum_1w": 0.019987392958933814,
    "FundamentalFilterRating": 66,
    "price": 48.47999954223633,
    "RSI (14)": 50.65,
    "EMA (20)": 47.73,
    "MACD (12,26,9)": 0.4237,
    "MACD_Signal (12,26,9)": 0.4193,
    "percent_change": 0.87,
    "TechFilterRating": 100.0,
    "news_sentiment_percent": 75.0,
    "social_sentiment_percent": null,
    "sector": "Energy",
    "sector_name": "XLE",
    "market_change_1d": 0.37538357962292324,
    "market_change_5d": -3.0471785979927946,
    "market_change_20d": -0.8544010945476632,
    "market_trend": "down",
    "sector_change_1d": -1.2958492607212047,
    "sector_change_5d": -0.4099753424731678,
    "sector_change_20d": 2.3690138147649087,
    "sector_trend": "neutral",
    "OverallRating": 80.3,
    "AITicker": "Baker Hughes is an energy technology company, primarily engaged in the oilfield services and equipment sector.",
    "AIComment": "Despite a general market downturn over the past 5 days, Baker Hughes shows resilience with a positive momentum and a slight increase in price. The neutral sector trend and positive news sentiment suggest stability, but the overall market negativity could limit upside potential in the short term. Technical indicators like a positive MACD above its signal and a stable RSI suggest a balanced outlook.",
    "AIScore": 65,
    "SL": 47.03,
    "TP": 50.42,
    "SL10": 9.7,
    "TP10": 10.4
  },
  {
    "ticker": "JNJ",
    "name": "Johnson & Johnson",
    "marketCap": 487906344960,
    "revenueGrowth": 0.068,
    "debtToEquity": 57.766,
    "trailingPE": 19.566183,
    "momentum_2m": 0.147430382479532,
    "momentum_1w": 0.04177167108741653,
    "FundamentalFilterRating": 83,
    "price": 202.50999450683594,
    "RSI (14)": 81.22,
    "EMA (20)": 193.66,
    "MACD (12,26,9)": 1.9962,
    "MACD_Signal (12,26,9)": 0.3337,
    "percent_change": 1.25,
    "TechFilterRating": 75.0,
    "news_sentiment_percent": 75.0,
    "social_sentiment_percent": null,
    "sector": "Healthcare",
    "sector_name": "XLV",
    "market_change_1d": 0.37538357962292324,
    "market_change_5d": -3.0471785979927946,
    "market_change_20d": -0.8544010945476632,
    "market_trend": "down",
    "sector_change_1d": -0.17038764865044964,
    "sector_change_5d": -0.3206422390259922,
    "sector_change_20d": 4.364205826377443,
    "sector_trend": "neutral",
    "OverallRating": 77.7,
    "AITicker": "Johnson & Johnson, a major player in the healthcare sector, primarily focuses on manufacturing pharmaceuticals, medical devices, and consumer health products.",
    "AIComment": "Despite a recent downturn in the broader market, Johnson & Johnson shows strong individual performance with a high RSI indicating potential overbought conditions, which could lead to a price pullback in the short term. The positive momentum and MACD values suggest underlying strength, but caution is advised due to the high RSI and the overall market trend.",
    "AIScore": 65,
    "SL": 196.43,
    "TP": 210.61,
    "SL10": 9.7,
    "TP10": 10.4
  },
  {
    "ticker": "REGN",
    "name": "Regeneron Pharmaceuticals",
    "marketCap": 74482671616,
    "revenueGrowth": 0.009,
    "debtToEquity": 8.739,
    "trailingPE": 16.836367,
    "momentum_2m": 0.19586483587863723,
    "momentum_1w": 0.030848486476323433,
    "FundamentalFilterRating": 66,
    "price": 702.75,
    "RSI (14)": 65.76,
    "EMA (20)": 661.32,
    "MACD (12,26,9)": 30.1946,
    "MACD_Signal (12,26,9)": 25.2162,
    "percent_change": -3.11,
    "TechFilterRating": 100.0,
    "news_sentiment_percent": 66.7,
    "social_sentiment_percent": null,
    "sector": "Healthcare",
    "sector_name": "XLV",
    "market_change_1d": 0.37538357962292324,
    "market_change_5d": -3.0471785979927946,
    "market_change_20d": -0.8544010945476632,
    "market_trend": "down",
    "sector_change_1d": -0.17038764865044964,
    "sector_change_5d": -0.3206422390259922,
    "sector_change_20d": 4.364205826377443,
    "sector_trend": "neutral",
    "OverallRating": 77.6,
    "AITicker": "Regeneron Pharmaceuticals, a healthcare company, specializes in the development of biopharmaceutical products.",
    "AIComment": "Despite a recent market downturn, Regeneron Pharmaceuticals shows strong individual performance indicators such as a positive MACD above its signal, a robust RSI, and a recent price above its EMA(20). However, the overall negative market trend and a neutral sector outlook might limit upside potential in the short term. Caution is advised for trading within the next 2-10 days.",
    "AIScore": 65,
    "SL": 681.67,
    "TP": 737.89,
    "SL10": 9.7,
    "TP10": 10.5
  },
  {
    "ticker": "UHS",
    "name": "Universal Health Services",
    "marketCap": 14505803776,
    "revenueGrowth": 0.134,
    "debtToEquity": 70.037,
    "trailingPE": 10.843958,
    "momentum_2m": 0.25759906061493587,
    "momentum_1w": -0.0021013734847508125,
    "FundamentalFilterRating": 66,
    "price": 227.94000244140625,
    "RSI (14)": 62.34,
    "EMA (20)": 222.67,
    "MACD (12,26,9)": 4.4781,
    "MACD_Signal (12,26,9)": 4.4578,
    "percent_change": -0.39,
    "TechFilterRating": 75.0,
    "news_sentiment_percent": 75.0,
    "social_sentiment_percent": null,
    "sector": "Healthcare",
    "sector_name": "XLV",
    "market_change_1d": 0.37538357962292324,
    "market_change_5d": -3.0471785979927946,
    "market_change_20d": -0.8544010945476632,
    "market_trend": "down",
    "sector_change_1d": -0.17038764865044964,
    "sector_change_5d": -0.3206422390259922,
    "sector_change_20d": 4.364205826377443,
    "sector_trend": "neutral",
    "OverallRating": 72.0,
    "AITicker": "Universal Health Services (UHS) is a company in the healthcare sector, providing hospital and healthcare services.",
    "AIComment": "Despite a recent downturn in the broader market, UHS shows resilience with a positive revenue growth and a stable debt-to-equity ratio. The stock's technical indicators such as a positive MACD above its signal and a strong RSI suggest potential for short-term gains. However, the neutral sector trend and slight negative momentum over the past week could limit upside potential.",
    "AIScore": 65,
    "SL": 221.1,
    "TP": 239.34,
    "SL10": 9.7,
    "TP10": 10.5
  },
  {
    "ticker": "PODD",
    "name": "Insulet Corporation",
    "marketCap": 24381157376,
    "revenueGrowth": 0.299,
    "debtToEquity": 77.711,
    "trailingPE": 100.97958,
    "momentum_2m": 0.043787479634944226,
    "momentum_1w": 0.028262644333133746,
    "FundamentalFilterRating": 66,
    "price": 346.3599853515625,
    "RSI (14)": 74.26,
    "EMA (20)": 328.0,
    "MACD (12,26,9)": 3.18,
    "MACD_Signal (12,26,9)": 0.792,
    "percent_change": 3.87,
    "TechFilterRating": 75.0,
    "news_sentiment_percent": 66.7,
    "social_sentiment_percent": null,
    "sector": "Healthcare",
    "sector_name": "XLV",
    "market_change_1d": 0.37538357962292324,
    "market_change_5d": -3.0471785979927946,
    "market_change_20d": -0.8544010945476632,
    "market_trend": "down",
    "sector_change_1d": -0.17038764865044964,
    "sector_change_5d": -0.3206422390259922,
    "sector_change_20d": 4.364205826377443,
    "sector_trend": "neutral",
    "OverallRating": 69.2,
    "AITicker": "Insulet Corporation, a healthcare company, specializes in manufacturing wearable insulin delivery systems.",
    "AIComment": "Despite a recent downturn in the broader market, Insulet Corporation shows strong individual performance with a significant price increase and positive momentum indicators. The stock's high RSI suggests it might be overbought, which could lead to a short-term pullback. However, the positive news sentiment and robust revenue growth indicate underlying strength, making it a potentially suitable but cautious trade for the short term.",
    "AIScore": 65,
    "SL": 335.97,
    "TP": 356.75,
    "SL10": 9.7,
    "TP10": 10.3
  },
  {
    "ticker": "OKE",
    "name": "Oneok",
    "marketCap": 43736551424,
    "revenueGrowth": 0.719,
    "debtToEquity": 152.218,
    "trailingPE": 12.766543,
    "momentum_2m": -0.052212714912702185,
    "momentum_1w": 0.007982516838649145,
    "FundamentalFilterRating": 66,
    "price": 69.44999694824219,
    "RSI (14)": 66.83,
    "EMA (20)": 68.25,
    "MACD (12,26,9)": 0.586,
    "MACD_Signal (12,26,9)": 0.3132,
    "percent_change": 0.03,
    "TechFilterRating": 75.0,
    "news_sentiment_percent": 66.7,
    "social_sentiment_percent": null,
    "sector": "Energy",
    "sector_name": "XLE",
    "market_change_1d": 0.37538357962292324,
    "market_change_5d": -3.0471785979927946,
    "market_change_20d": -0.8544010945476632,
    "market_trend": "down",
    "sector_change_1d": -1.2958492607212047,
    "sector_change_5d": -0.4099753424731678,
    "sector_change_20d": 2.3690138147649087,
    "sector_trend": "neutral",
    "OverallRating": 69.2,
    "AITicker": "Oneok, Inc. (OKE) is an energy company primarily involved in the gathering, processing, storage, and transportation of natural gas.",
    "AIComment": "Despite a general market downturn over the past 5 days, Oneok has shown resilience with a slight positive momentum this week and a robust RSI indicating strong buying interest. The neutral sector trend and positive news sentiment further support potential stability. However, high debt-to-equity ratio and recent market volatility suggest caution.",
    "AIScore": 65,
    "SL": 67.37,
    "TP": 72.23,
    "SL10": 9.7,
    "TP10": 10.4
  },
  {
    "ticker": "EW",
    "name": "Edwards Lifesciences",
    "marketCap": 50502344704,
    "revenueGrowth": 0.147,
    "debtToEquity": 6.862,
    "trailingPE": 37.72807,
    "momentum_2m": 0.05844715388462185,
    "momentum_1w": 0.005141327443300536,
    "FundamentalFilterRating": 66,
    "price": 86.0199966430664,
    "RSI (14)": 60.13,
    "EMA (20)": 83.01,
    "MACD (12,26,9)": 2.1765,
    "MACD_Signal (12,26,9)": 2.1885,
    "percent_change": 2.36,
    "TechFilterRating": 75.0,
    "news_sentiment_percent": 61.1,
    "social_sentiment_percent": null,
    "sector": "Healthcare",
    "sector_name": "XLV",
    "market_change_1d": 0.37538357962292324,
    "market_change_5d": -3.0471785979927946,
    "market_change_20d": -0.8544010945476632,
    "market_trend": "down",
    "sector_change_1d": -0.17038764865044964,
    "sector_change_5d": -0.3206422390259922,
    "sector_change_20d": 4.364205826377443,
    "sector_trend": "neutral",
    "OverallRating": 67.4,
    "AITicker": "Edwards Lifesciences is a company in the healthcare sector, specializing in innovative solutions for heart disease and critical care monitoring.",
    "AIComment": "Despite a recent market downturn, Edwards Lifesciences shows resilience with a positive momentum over the last week and a stable RSI, suggesting it might withstand short-term market volatility. However, the neutral sector trend and slight underperformance compared to the MACD signal indicate potential risks. The positive news sentiment and revenue growth are encouraging, but caution is advised due to mixed technical indicators.",
    "AIScore": 65,
    "SL": 83.44,
    "TP": 89.46,
    "SL10": 9.7,
    "TP10": 10.4
  },
  {
    "ticker": "IQV",
    "name": "IQVIA",
    "marketCap": 37036843008,
    "revenueGrowth": 0.052,
    "debtToEquity": 242.366,
    "trailingPE": 29.955921,
    "momentum_2m": 0.15828718624947058,
    "momentum_1w": -0.015393014669106475,
    "FundamentalFilterRating": 66,
    "price": 217.47999572753906,
    "RSI (14)": 51.72,
    "EMA (20)": 216.35,
    "MACD (12,26,9)": 1.1558,
    "MACD_Signal (12,26,9)": 0.9541,
    "percent_change": 0.09,
    "TechFilterRating": 75.0,
    "news_sentiment_percent": 66.7,
    "social_sentiment_percent": null,
    "sector": "Healthcare",
    "sector_name": "XLV",
    "market_change_1d": 0.37538357962292324,
    "market_change_5d": -3.0471785979927946,
    "market_change_20d": -0.8544010945476632,
    "market_trend": "down",
    "sector_change_1d": -0.17038764865044964,
    "sector_change_5d": -0.3206422390259922,
    "sector_change_20d": 4.364205826377443,
    "sector_trend": "neutral",
    "OverallRating": 69.2,
    "AITicker": "IQVIA is a global provider of advanced analytics, technology solutions, and clinical research services to the healthcare industry.",
    "AIComment": "IQVIA presents a mixed short-term trading opportunity. The overall market is trending downward, which could negatively impact the stock. However, the healthcare sector remains neutral, and IQVIA's technical indicators like a positive MACD above its signal and a stable RSI suggest some resilience. The positive news sentiment and recent revenue growth also support potential stability.",
    "AIScore": 58,
    "SL": 212.02,
    "TP": 228.35,
    "SL10": 9.75,
    "TP10": 10.5
  },
  {
    "ticker": "MRK",
    "name": "Merck & Co.",
    "marketCap": 237414318080,
    "revenueGrowth": 0.037,
    "debtToEquity": 79.708,
    "trailingPE": 12.572752,
    "momentum_2m": 0.1294141899905048,
    "momentum_1w": 0.03936584170202995,
    "FundamentalFilterRating": 83,
    "price": 95.05000305175781,
    "RSI (14)": 72.78,
    "EMA (20)": 89.8,
    "MACD (12,26,9)": 2.1326,
    "MACD_Signal (12,26,9)": 1.1318,
    "percent_change": -1.43,
    "TechFilterRating": 75.0,
    "news_sentiment_percent": 75.0,
    "social_sentiment_percent": null,
    "sector": "Healthcare",
    "sector_name": "XLV",
    "market_change_1d": 0.37538357962292324,
    "market_change_5d": -3.0471785979927946,
    "market_change_20d": -0.8544010945476632,
    "market_trend": "down",
    "sector_change_1d": -0.17038764865044964,
    "sector_change_5d": -0.3206422390259922,
    "sector_change_20d": 4.364205826377443,
    "sector_trend": "neutral",
    "OverallRating": 77.7,
    "AITicker": "Merck & Co., známa farmaceutická spoločnosť, sa zameriava na vývoj a distribúciu liekov a vakcín.",
    "AIComment": "Merck & Co. vykazuje silný technický profil s RSI nad 70, čo naznačuje prekúpenosť, a pozitívny MACD nad signálom. Avšak, negatívny trhový trend a neutrálny sektorový trend môžu obmedziť krátkodobý rast. Vzhľadom na tieto faktory a nedávny pokles ceny o 1.43%, môže byť riziko obchodovania v nasledujúcich 2-10 dňoch vyššie.",
    "AIScore": 55,
    "SL": 92.2,
    "TP": 98.85,
    "SL10": 9.7,
    "TP10": 10.4
  },
  {
    "ticker": "CTRA",
    "name": "Coterra",
    "marketCap": 19658485760,
    "revenueGrowth": 0.349,
    "debtToEquity": 27.957,
    "trailingPE": 11.925925,
    "momentum_2m": 0.08697605461512503,
    "momentum_1w": -0.005789182674912796,
    "FundamentalFilterRating": 66,
    "price": 25.760000228881836,
    "RSI (14)": 70.89,
    "EMA (20)": 25.23,
    "MACD (12,26,9)": 0.7217,
    "MACD_Signal (12,26,9)": 0.6896,
    "percent_change": -1.57,
    "TechFilterRating": 75.0,
    "news_sentiment_percent": 91.7,
    "social_sentiment_percent": null,
    "sector": "Energy",
    "sector_name": "XLE",
    "market_change_1d": 0.37538357962292324,
    "market_change_5d": -3.0471785979927946,
    "market_change_20d": -0.8544010945476632,
    "market_trend": "down",
    "sector_change_1d": -1.2958492607212047,
    "sector_change_5d": -0.4099753424731678,
    "sector_change_20d": 2.3690138147649087,
    "sector_trend": "neutral",
    "OverallRating": 77.6,
    "AITicker": "Coterra is an energy company involved in the exploration and production of oil and natural gas.",
    "AIComment": "Despite a recent market downturn, Coterra's strong revenue growth and positive news sentiment suggest resilience. However, the overall negative market trend and neutral sector performance might limit short-term gains. The high RSI indicates potential overbought conditions, suggesting caution for a 2-10 day trading window.",
    "AIScore": 55,
    "SL": 24.99,
    "TP": 26.53,
    "SL10": 9.7,
    "TP10": 10.3
  },
  {
    "ticker": "XOM",
    "name": "ExxonMobil",
    "marketCap": 500292026368,
    "revenueGrowth": -0.051,
    "debtToEquity": 15.672,
    "trailingPE": 17.056686,
    "momentum_2m": 0.0617671241566895,
    "momentum_1w": 0.0021707086853042235,
    "FundamentalFilterRating": 66,
    "price": 117.3499984741211,
    "RSI (14)": 61.22,
    "EMA (20)": 115.96,
    "MACD (12,26,9)": 1.5155,
    "MACD_Signal (12,26,9)": 1.2653,
    "percent_change": -1.41,
    "TechFilterRating": 100.0,
    "news_sentiment_percent": 66.7,
    "social_sentiment_percent": null,
    "sector": "Energy",
    "sector_name": "XLE",
    "market_change_1d": 0.37538357962292324,
    "market_change_5d": -3.0471785979927946,
    "market_change_20d": -0.8544010945476632,
    "market_trend": "down",
    "sector_change_1d": -1.2958492607212047,
    "sector_change_5d": -0.4099753424731678,
    "sector_change_20d": 2.3690138147649087,
    "sector_trend": "neutral",
    "OverallRating": 77.6,
    "AITicker": "ExxonMobil, a major player in the energy sector, primarily engages in the exploration and production of oil and natural gas.",
    "AIComment": "Considering the current market and sector trends, ExxonMobil presents a cautious short-term trading opportunity. The overall market is trending downwards, which could negatively impact the stock. However, the neutral trend in the energy sector and ExxonMobil's stable fundamentals, such as a reasonable debt-to-equity ratio and positive momentum indicators, might buffer against larger market downturns.",
    "AIScore": 55,
    "SL": 113.83,
    "TP": 122.04,
    "SL10": 9.7,
    "TP10": 10.4
  },
  {
    "ticker": "INCY",
    "name": "Incyte",
    "marketCap": 19891417088,
    "revenueGrowth": 0.2,
    "debtToEquity": 0.887,
    "trailingPE": 17.17288,
    "momentum_2m": 0.20619047255743128,
    "momentum_1w": -0.06410495385611759,
    "FundamentalFilterRating": 83,
    "price": 101.31999969482422,
    "RSI (14)": 68.46,
    "EMA (20)": 100.45,
    "MACD (12,26,9)": 4.0491,
    "MACD_Signal (12,26,9)": 4.4561,
    "percent_change": -2.47,
    "TechFilterRating": 75.0,
    "news_sentiment_percent": 66.7,
    "social_sentiment_percent": null,
    "sector": "Healthcare",
    "sector_name": "XLV",
    "market_change_1d": 0.37538357962292324,
    "market_change_5d": -3.0471785979927946,
    "market_change_20d": -0.8544010945476632,
    "market_trend": "down",
    "sector_change_1d": -0.17038764865044964,
    "sector_change_5d": -0.3206422390259922,
    "sector_change_20d": 4.364205826377443,
    "sector_trend": "neutral",
    "OverallRating": 74.9,
    "AITicker": "Incyte is a biopharmaceutical company focused on the discovery, development, and commercialization of proprietary therapeutics.",
    "AIComment": "Despite a recent downturn in the broader market and a neutral sector trend, Incyte shows potential resilience given its positive revenue growth and strong fundamentals like a reasonable debt-to-equity ratio and a solid trailing PE. However, the recent negative momentum and a slight underperformance compared to its EMA and MACD signal caution for a short-term trading window of 2-10 days.",
    "AIScore": 55,
    "SL": 98.44,
    "TP": 106.39,
    "SL10": 9.72,
    "TP10": 10.5
  },
  {
    "ticker": "BIIB",
    "name": "Biogen",
    "marketCap": 24635711488,
    "revenueGrowth": 0.028,
    "debtToEquity": 36.194,
    "trailingPE": 15.308112,
    "momentum_2m": 0.22827670550336476,
    "momentum_1w": 0.039943009158391884,
    "FundamentalFilterRating": 66,
    "price": 167.92999267578125,
    "RSI (14)": 73.98,
    "EMA (20)": 158.35,
    "MACD (12,26,9)": 5.092,
    "MACD_Signal (12,26,9)": 3.7169,
    "percent_change": -0.53,
    "TechFilterRating": 75.0,
    "news_sentiment_percent": 75.0,
    "social_sentiment_percent": null,
    "sector": "Healthcare",
    "sector_name": "XLV",
    "market_change_1d": 0.37538357962292324,
    "market_change_5d": -3.0471785979927946,
    "market_change_20d": -0.8544010945476632,
    "market_trend": "down",
    "sector_change_1d": -0.17038764865044964,
    "sector_change_5d": -0.3206422390259922,
    "sector_change_20d": 4.364205826377443,
    "sector_trend": "neutral",
    "OverallRating": 72.0,
    "AITicker": "Biogen is a biotechnology company specializing in therapies for neurological and neurodegenerative diseases.",
    "AIComment": "Biogen's stock shows mixed signals for short-term trading. The overall market is trending down, which could negatively impact the stock. However, the healthcare sector remains neutral, and Biogen's technical indicators like a high RSI and positive MACD suggest some bullish momentum. Caution is advised due to the market's negative trend.",
    "AIScore": 55,
    "SL": 162.89,
    "TP": 174.65,
    "SL10": 9.7,
    "TP10": 10.4
  },
  {
    "ticker": "VRTX",
    "name": "Vertex Pharmaceuticals",
    "marketCap": 107948154880,
    "revenueGrowth": 0.11,
    "debtToEquity": 10.594,
    "trailingPE": 29.587492,
    "momentum_2m": 0.08742705393835037,
    "momentum_1w": -0.030309319855620798,
    "FundamentalFilterRating": 66,
    "price": 421.0299987792969,
    "RSI (14)": 50.82,
    "EMA (20)": 425.79,
    "MACD (12,26,9)": 2.8397,
    "MACD_Signal (12,26,9)": 2.1985,
    "percent_change": -3.33,
    "TechFilterRating": 75.0,
    "news_sentiment_percent": 66.7,
    "social_sentiment_percent": null,
    "sector": "Healthcare",
    "sector_name": "XLV",
    "market_change_1d": 0.37538357962292324,
    "market_change_5d": -3.0471785979927946,
    "market_change_20d": -0.8544010945476632,
    "market_trend": "down",
    "sector_change_1d": -0.17038764865044964,
    "sector_change_5d": -0.3206422390259922,
    "sector_change_20d": 4.364205826377443,
    "sector_trend": "neutral",
    "OverallRating": 69.2,
    "AITicker": "Vertex Pharmaceuticals is a biotechnology firm specializing in the development and commercialization of therapies for the treatment of cystic fibrosis and other severe diseases.",
    "AIComment": "Given the recent market downturn and the neutral sector trend, Vertex Pharmaceuticals presents a risky short-term trading opportunity. The stock's negative momentum over the past week and a 3.33% decline in price suggest potential volatility. However, positive news sentiment and a stable RSI might buffer some downside risks.",
    "AIScore": 45,
    "SL": 417.27,
    "TP": 437.87,
    "SL10": 9.91,
    "TP10": 10.4
  },
  {
    "ticker": "ELV",
    "name": "Elevance Health",
    "marketCap": 71239655424,
    "revenueGrowth": 0.123,
    "debtToEquity": 72.823,
    "trailingPE": 12.886762,
    "momentum_2m": 0.02601779703541096,
    "momentum_1w": -0.03436806640970658,
    "FundamentalFilterRating": 66,
    "price": 316.3699951171875,
    "RSI (14)": 46.56,
    "EMA (20)": 326.83,
    "MACD (12,26,9)": -6.1106,
    "MACD_Signal (12,26,9)": -7.341,
    "percent_change": -2.51,
    "TechFilterRating": 75.0,
    "news_sentiment_percent": 66.7,
    "social_sentiment_percent": null,
    "sector": "Healthcare",
    "sector_name": "XLV",
    "market_change_1d": 0.37538357962292324,
    "market_change_5d": -3.0471785979927946,
    "market_change_20d": -0.8544010945476632,
    "market_trend": "down",
    "sector_change_1d": -0.17038764865044964,
    "sector_change_5d": -0.3206422390259922,
    "sector_change_20d": 4.364205826377443,
    "sector_trend": "neutral",
    "OverallRating": 69.2,
    "AITicker": "Elevance Health, formerly known as Anthem, is a healthcare services provider specializing in health insurance.",
    "AIComment": "Elevance Health (ELV) shows a negative short-term trading outlook due to its recent price decline and unfavorable market conditions. The overall market trend is down, and the healthcare sector is neutral, which might not support a quick recovery. Technical indicators like a lower MACD than its signal and a below-average RSI suggest limited upward momentum in the next 2-10 days.",
    "AIScore": 35,
    "SL": 320.29,
    "TP": 329.02,
    "SL10": 10.12,
    "TP10": 10.4
  }
]